Trials / Completed
CompletedNCT01509261
Efficacy Study of Ilaprazole to Treat Erosive Esophgitis
A Phase Ⅲ Multi-center, Randomized, Double-blind, Active-controlled Study to Evaluate the Efficacy and Safety of Ilaprazole (20mg QD) in Adult Patients With Erosive Esophagitis
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 292 (actual)
- Sponsor
- Il-Yang Pharm. Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This study compared Ilaprazole 20mg with lansoprazole 30mg for the healing of erosive esophagitis and resolution of heartburn.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ilaprazole | 20mg/Tap, QD |
| DRUG | Lansoprazole | 30mg/Tap, QD |
Timeline
- Start date
- 2010-07-01
- Primary completion
- 2011-06-01
- Completion
- 2011-06-01
- First posted
- 2012-01-12
- Last updated
- 2012-01-12
Locations
19 sites across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01509261. Inclusion in this directory is not an endorsement.